VRNS INVESTOR DEADLINE: Varonis Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

San Diego, California–(Newsfile Corp. – January 14, 2026) – Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Varonis Systems, Inc. (NASDAQ: VRNS) common stock between February 4, 2025 and October 28, 2025, both dates inclusive (the “Class Period”), have until March 9, 2026 to seek appointment as lead plaintiff of the […]

USISPF applauds Ambassador Sergio Gor’s vision for expanding US-India partnership

USISPF applauds Ambassador Sergio Gor's vision for expanding US-India partnership GlobeNewswire January 14, 2026 Washington, DC, Jan. 14, 2026 (GLOBE NEWSWIRE) — USISPF congratulates Ambassador Sergio Gor on assuming charge in New Delhi as the Ambassador to India and as Special Presidential Envoy for South and Central Asian Affairs (SCA). United States Ambassador to the

Winter Commutes Just Got Warmer: The Bahamas Brings “A Lifetime of Islands” to New York’s Moynihan Train Hall

Winter Commutes Just Got Warmer: The Bahamas Brings “A Lifetime of Islands” to New York's Moynihan Train Hall GlobeNewswire January 14, 2026 Nassau, The Bahamas, Jan. 14, 2026 (GLOBE NEWSWIRE) — The Bahamas Ministry of Tourism, Investments & Aviation (BMOTIA) has launched a high-impact out-of-home advertising activation at New York City's Moynihan Train Hall, bringing

Meta to Announce Fourth Quarter and Full Year 2025 Results

Meta Platforms, Inc. (NASDAQ: META) announced today that the company’s fourth quarter and full year 2025 financial results will be released after market close on Wednesday, January 28th, 2026. Meta will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. The live webcast of the

Flex Announces Third Quarter Fiscal Year 2026 Earnings Call Date

Flex (NASDAQ: FLEX) will announce its third quarter fiscal year 2026 financial results before the market opens on Wednesday, Feb. 4, 2026. The company will hold a conference call to discuss the results that day at 7:30 AM CT / 8:30 AM ET. The live webcast presentation will be available on the Flex investor relations

S&P Global Increases Dividend 1.0% to $0.97

The Board of Directors of S&P Global (NYSE: SPGI) today approved a 1.0% increase in the regular quarterly cash dividend on the Company’s common stock. The 1.0% increase takes into consideration the expected spin of S&P Global’s Mobility division into an independent, public company in 2026. The Company has paid a dividend each year since

ADP Declares Regular Quarterly Dividend

The board of directors of Automatic Data Processing, Inc. (Nasdaq: ADP) has declared a regular quarterly dividend of $1.70 per share payable April 1, 2026 to shareholders of record on March 13, 2026. About ADP (Nasdaq: ADP)ADP has been shaping the world of work with innovation and expertise for more than 75 years. As a

Caterpillar Announces Leadership Transition in Construction Industries

Caterpillar Inc. (NYSE: CAT) today announced that Tony Fassino, group president of Construction Industries, has elected to retire effective May 31, 2026, following 30 years with the company. Caterpillar veteran Rod Shurman has been appointed group president of Construction Industries effective Feb. 1, 2026, at which time Fassino will become group president, retired, for the

Safe & Green Holdings Corp. Adjourns 2025 Annual Meeting Due to Lack of Quorum

(NASDAQ:SGBX), CONROE, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) — via IBN – Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green” or the “Company”) announced today that its 2025 Annual Meeting of Stockholders, convened on Jan. 14, 2026, was adjourned after a quorum was not present in person or by proxy. As a result,

INVESTOR ALERT: Investigation of Travere Therapeutics, Inc. (TVTX) by Holzer & Holzer, LLC

(NasdaqGM:TVTX), ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Travere Therapeutics, Inc. (“Travere” or the “Company”) (NASDAQ: TVTX) complied with federal securities laws. On January 13, 2026, Travere disclosed that the U.S. Food and Drug Administration has extended the review timeline of its supplemental New Drug Application for FILSPARI(R)

Scroll to Top